A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk

Howard D. Hosgood, Mark P. Purdue, Sophia S. Wang, Tongzhang Zheng, Lindsay M. Morton, Qing Lan, Idan Menashe, Yawei Zhang, James R. Cerhan, Andrew Grulich, Wendy Cozen, Meredith Yeager, Theodore R. Holford, Claire M. Vajdic, Scott Davis, Brian Leaderer, Anne Kricker, Maryjean Schenk, Shelia H. Zahm, Nilanjan ChatterjeeStephen J. Chanock, Nathaniel Rothman, Patricia Hartge, Bruce Armstrong

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Genetic variation in immune-related genes may play a role in the development of non-Hodgkin lymphoma (NHL). To test the hypothesis that innate immunity polymorphisms may be associated with NHL risk, we genotyped 144 tag single nucleotide polymorphisms (tagSNPs) capturing common genetic variation within 12 innate immunity gene regions in three independent population-based case-control studies (1946 cases and 1808 controls). Gene-based analyses found IL1RN to be associated with NHL risk (minP=0·03); specifically, IL1RN rs2637988 was associated with an increased risk of NHL (per-allele odds ratio=1·15, 95% confidence interval=1·05-1·27; Ptrend=0·003), which was consistent across study, subtype, and gender. FCGR2A was also associated with a decreased risk of the follicular lymphoma NHL subtype (minP=0·03). Our findings suggest that genetic variation in IL1RN and FCGR2A may play a role in lymphomagenesis. Given that conflicting results have been reported regarding the association between IL1RN SNPs and NHL risk, a larger number of innate immunity genes with sufficient genomic coverage should be evaluated systematically across many studies. Published 2011. This article is a US Government work and is in the public domain in the USA..

Original languageEnglish (US)
Pages (from-to)721-726
Number of pages6
JournalBritish Journal of Haematology
Volume152
Issue number6
DOIs
StatePublished - Mar 2011
Externally publishedYes

Fingerprint

Innate Immunity
Non-Hodgkin's Lymphoma
Genes
Single Nucleotide Polymorphism
Follicular Lymphoma
Public Sector
Case-Control Studies
Alleles
Odds Ratio
Confidence Intervals
Population

Keywords

  • Genetic variation
  • Immune
  • Innate immunity
  • Non-Hodgkin lymphoma
  • Single nucleotide polymorphisms

ASJC Scopus subject areas

  • Hematology

Cite this

A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk. / Hosgood, Howard D.; Purdue, Mark P.; Wang, Sophia S.; Zheng, Tongzhang; Morton, Lindsay M.; Lan, Qing; Menashe, Idan; Zhang, Yawei; Cerhan, James R.; Grulich, Andrew; Cozen, Wendy; Yeager, Meredith; Holford, Theodore R.; Vajdic, Claire M.; Davis, Scott; Leaderer, Brian; Kricker, Anne; Schenk, Maryjean; Zahm, Shelia H.; Chatterjee, Nilanjan; Chanock, Stephen J.; Rothman, Nathaniel; Hartge, Patricia; Armstrong, Bruce.

In: British Journal of Haematology, Vol. 152, No. 6, 03.2011, p. 721-726.

Research output: Contribution to journalArticle

Hosgood, HD, Purdue, MP, Wang, SS, Zheng, T, Morton, LM, Lan, Q, Menashe, I, Zhang, Y, Cerhan, JR, Grulich, A, Cozen, W, Yeager, M, Holford, TR, Vajdic, CM, Davis, S, Leaderer, B, Kricker, A, Schenk, M, Zahm, SH, Chatterjee, N, Chanock, SJ, Rothman, N, Hartge, P & Armstrong, B 2011, 'A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk', British Journal of Haematology, vol. 152, no. 6, pp. 721-726. https://doi.org/10.1111/j.1365-2141.2010.08518.x
Hosgood, Howard D. ; Purdue, Mark P. ; Wang, Sophia S. ; Zheng, Tongzhang ; Morton, Lindsay M. ; Lan, Qing ; Menashe, Idan ; Zhang, Yawei ; Cerhan, James R. ; Grulich, Andrew ; Cozen, Wendy ; Yeager, Meredith ; Holford, Theodore R. ; Vajdic, Claire M. ; Davis, Scott ; Leaderer, Brian ; Kricker, Anne ; Schenk, Maryjean ; Zahm, Shelia H. ; Chatterjee, Nilanjan ; Chanock, Stephen J. ; Rothman, Nathaniel ; Hartge, Patricia ; Armstrong, Bruce. / A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk. In: British Journal of Haematology. 2011 ; Vol. 152, No. 6. pp. 721-726.
@article{66de287453934781a8461e2a60d0bcab,
title = "A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk",
abstract = "Genetic variation in immune-related genes may play a role in the development of non-Hodgkin lymphoma (NHL). To test the hypothesis that innate immunity polymorphisms may be associated with NHL risk, we genotyped 144 tag single nucleotide polymorphisms (tagSNPs) capturing common genetic variation within 12 innate immunity gene regions in three independent population-based case-control studies (1946 cases and 1808 controls). Gene-based analyses found IL1RN to be associated with NHL risk (minP=0·03); specifically, IL1RN rs2637988 was associated with an increased risk of NHL (per-allele odds ratio=1·15, 95{\%} confidence interval=1·05-1·27; Ptrend=0·003), which was consistent across study, subtype, and gender. FCGR2A was also associated with a decreased risk of the follicular lymphoma NHL subtype (minP=0·03). Our findings suggest that genetic variation in IL1RN and FCGR2A may play a role in lymphomagenesis. Given that conflicting results have been reported regarding the association between IL1RN SNPs and NHL risk, a larger number of innate immunity genes with sufficient genomic coverage should be evaluated systematically across many studies. Published 2011. This article is a US Government work and is in the public domain in the USA..",
keywords = "Genetic variation, Immune, Innate immunity, Non-Hodgkin lymphoma, Single nucleotide polymorphisms",
author = "Hosgood, {Howard D.} and Purdue, {Mark P.} and Wang, {Sophia S.} and Tongzhang Zheng and Morton, {Lindsay M.} and Qing Lan and Idan Menashe and Yawei Zhang and Cerhan, {James R.} and Andrew Grulich and Wendy Cozen and Meredith Yeager and Holford, {Theodore R.} and Vajdic, {Claire M.} and Scott Davis and Brian Leaderer and Anne Kricker and Maryjean Schenk and Zahm, {Shelia H.} and Nilanjan Chatterjee and Chanock, {Stephen J.} and Nathaniel Rothman and Patricia Hartge and Bruce Armstrong",
year = "2011",
month = "3",
doi = "10.1111/j.1365-2141.2010.08518.x",
language = "English (US)",
volume = "152",
pages = "721--726",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk

AU - Hosgood, Howard D.

AU - Purdue, Mark P.

AU - Wang, Sophia S.

AU - Zheng, Tongzhang

AU - Morton, Lindsay M.

AU - Lan, Qing

AU - Menashe, Idan

AU - Zhang, Yawei

AU - Cerhan, James R.

AU - Grulich, Andrew

AU - Cozen, Wendy

AU - Yeager, Meredith

AU - Holford, Theodore R.

AU - Vajdic, Claire M.

AU - Davis, Scott

AU - Leaderer, Brian

AU - Kricker, Anne

AU - Schenk, Maryjean

AU - Zahm, Shelia H.

AU - Chatterjee, Nilanjan

AU - Chanock, Stephen J.

AU - Rothman, Nathaniel

AU - Hartge, Patricia

AU - Armstrong, Bruce

PY - 2011/3

Y1 - 2011/3

N2 - Genetic variation in immune-related genes may play a role in the development of non-Hodgkin lymphoma (NHL). To test the hypothesis that innate immunity polymorphisms may be associated with NHL risk, we genotyped 144 tag single nucleotide polymorphisms (tagSNPs) capturing common genetic variation within 12 innate immunity gene regions in three independent population-based case-control studies (1946 cases and 1808 controls). Gene-based analyses found IL1RN to be associated with NHL risk (minP=0·03); specifically, IL1RN rs2637988 was associated with an increased risk of NHL (per-allele odds ratio=1·15, 95% confidence interval=1·05-1·27; Ptrend=0·003), which was consistent across study, subtype, and gender. FCGR2A was also associated with a decreased risk of the follicular lymphoma NHL subtype (minP=0·03). Our findings suggest that genetic variation in IL1RN and FCGR2A may play a role in lymphomagenesis. Given that conflicting results have been reported regarding the association between IL1RN SNPs and NHL risk, a larger number of innate immunity genes with sufficient genomic coverage should be evaluated systematically across many studies. Published 2011. This article is a US Government work and is in the public domain in the USA..

AB - Genetic variation in immune-related genes may play a role in the development of non-Hodgkin lymphoma (NHL). To test the hypothesis that innate immunity polymorphisms may be associated with NHL risk, we genotyped 144 tag single nucleotide polymorphisms (tagSNPs) capturing common genetic variation within 12 innate immunity gene regions in three independent population-based case-control studies (1946 cases and 1808 controls). Gene-based analyses found IL1RN to be associated with NHL risk (minP=0·03); specifically, IL1RN rs2637988 was associated with an increased risk of NHL (per-allele odds ratio=1·15, 95% confidence interval=1·05-1·27; Ptrend=0·003), which was consistent across study, subtype, and gender. FCGR2A was also associated with a decreased risk of the follicular lymphoma NHL subtype (minP=0·03). Our findings suggest that genetic variation in IL1RN and FCGR2A may play a role in lymphomagenesis. Given that conflicting results have been reported regarding the association between IL1RN SNPs and NHL risk, a larger number of innate immunity genes with sufficient genomic coverage should be evaluated systematically across many studies. Published 2011. This article is a US Government work and is in the public domain in the USA..

KW - Genetic variation

KW - Immune

KW - Innate immunity

KW - Non-Hodgkin lymphoma

KW - Single nucleotide polymorphisms

UR - http://www.scopus.com/inward/record.url?scp=79952003247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952003247&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2010.08518.x

DO - 10.1111/j.1365-2141.2010.08518.x

M3 - Article

C2 - 21250972

AN - SCOPUS:79952003247

VL - 152

SP - 721

EP - 726

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 6

ER -